ROYAL BANK OF CANADA - EDGEWISE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EDGEWISE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,000
+12.5%
7,902
+53.0%
0.00%
Q2 2023$40,000
+110.5%
5,164
+82.8%
0.00%
Q1 2023$19,000
-51.3%
2,825
-35.4%
0.00%
Q4 2022$39,000
+225.0%
4,372
+260.7%
0.00%
Q3 2022$12,000
+50.0%
1,212
+19.1%
0.00%
Q2 2022$8,000
-74.2%
1,018
-68.5%
0.00%
Q1 2022$31,000
-87.0%
3,227
-79.4%
0.00%
Q4 2021$239,000
+895.8%
15,652
+1017.2%
0.00%
Q3 2021$24,000
+33.3%
1,401
+66.0%
0.00%
Q2 2021$18,0008440.00%
Other shareholders
EDGEWISE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,553,661$12,367,0008.01%
Cormorant Asset Management, LP 3,850,000$30,646,0002.32%
Novo Holdings A/S 5,587,207$44,474,0002.19%
Orbimed Advisors 14,082,680$112,098,0002.03%
Opaleye Management Inc. 451,400$3,593,0001.62%
DAFNA Capital Management LLC 695,959$5,540,0001.51%
EcoR1 Capital, LLC 2,359,808$18,784,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,933,137$31,308,0000.65%
Resolute Capital Asset Partners LLC 89,190$710,0000.51%
HighVista Strategies LLC 103,462$824,0000.50%
View complete list of EDGEWISE THERAPEUTICS INC shareholders